Cargando…
Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding and succeeding the advent of phosphodiesterase type 5 inhibitors
With advancing age, there is an increase in the complaints of a lack of a libido in women and erectile dysfunction in men. The efficacy of phosphodiesterase type 5 inhibitors, together with their minimal side effects and ease of administration, revolutionized the treatment of erectile dysfunction. F...
Autores principales: | Reis, Sandra Léa Bonfim, Abdo, Carmita H. N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971358/ https://www.ncbi.nlm.nih.gov/pubmed/24714838 http://dx.doi.org/10.6061/clinics/2014(04)11 |
Ejemplares similares
-
Is testosterone involved in low female sexual desire?
por: Abdo, Carmita H. N.
Publicado: (2019) -
Management of hypoactive sexual desire disorder in women in the gynecological setting: Number 5 - May 2021
por: Lara, Lucia Alves da Silva, et al.
Publicado: (2021) -
Clinically Meaningful Benefit in Women with Hypoactive Sexual Desire Disorder Treated with Flibanserin
por: Simon, James A., et al.
Publicado: (2022) -
The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review
por: Uloko, Maria, et al.
Publicado: (2022) -
Flibanserin for Treating Hypoactive Sexual Desire Disorder
por: Sang, Jae Hong, et al.
Publicado: (2016)